Comment
. 2002 Oct 1;20(19):4127-8; author reply 4128-9.
doi: 10.1200/JCO.2002.99.158.
Questionable benefit of melatonin for antioxidant pharmacologic therapy
- PMID: 12351615
- DOI: 10.1200/JCO.2002.99.158
Item in Clipboard
Comment
Questionable benefit of melatonin for antioxidant pharmacologic therapy
J Clin Oncol.
.
No abstract available
Comment on
-
Melatonin: from basic research to cancer treatment clinics.J Clin Oncol. 2002 May 15;20(10):2575-601. doi: 10.1200/JCO.2002.11.004. J Clin Oncol. 2002. PMID: 12011138 Review.
Similar articles
-
Melatonin: from basic research to cancer treatment clinics.J Clin Oncol. 2002 May 15;20(10):2575-601. doi: 10.1200/JCO.2002.11.004. J Clin Oncol. 2002. PMID: 12011138 Review.
-
[Melatonin and its wide-spectrum effects: use of melatonin in the treatment of tumors].Cesk Fysiol. 1999 Feb;48(1):27-40. Cesk Fysiol. 1999. PMID: 10377603 Review. Slovak.
-
Effects of melatonin on acute necrotizing pancreatitis in rats.Z Gastroenterol. 2004 Sep;42(9):967-72. doi: 10.1055/s-2004-813321. Z Gastroenterol. 2004. PMID: 15455265
-
Antioxidant properties of melatonin and its potential action in diseases.Curr Top Med Chem. 2015;15(9):894-903. doi: 10.2174/1568026615666150220120946. Curr Top Med Chem. 2015. PMID: 25697560 Review.
-
Melatonin: Quantum-chemical and biochemical investigation of antioxidant activity.Eur J Med Chem. 2009 Jul;44(7):2834-9. doi: 10.1016/j.ejmech.2008.12.017. Epub 2008 Dec 25. Eur J Med Chem. 2009. PMID: 19168264 Clinical Trial.
Cited by
-
The therapeutic potential of melatonin: a review of the science.MedGenMed. 2004 Apr 13;6(2):46. MedGenMed. 2004. PMID: 15266271 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
